AD

Ashwani Deedwania

Active Director Director DIN 08083495
DIN 08083495 First appointment Mar 2018 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Mar 2018
Shareholding value •••• Premium profile

About Ashwani Deedwania

Data last updated:

Ashwani Deedwania is a Director at Delicare Lifesciences Private Limited (since 2018), Director at Exeens Capital Advisors Private Limited (since 2018) and Designated Partner at Aavyana Advisors Llp (since 2023). The companies operate in Chemicals and Materials, Financial Services and Environment. The 2 current companies with reported revenue have a combined latest revenue of ₹10.09 Cr; the largest is Delicare Lifesciences Private Limited at ₹10.07 Cr (FY 2025). Earlier, Ashwani Deedwania was a Director at Verdeen Chemicals Private Limited (2018–2022) and Director at Bvg Tech Private Limited (from 2019).

DIN 08083495
Primary Designation Director
Industry Chemicals and Materials
First Appointment 12 Mar 2018
Oldest Company Age 15 yrs
Largest company Delicare Lifesciences Private Limited · ₹10.07 Cr (FY 2025)
Combined revenue ₹10.09 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 May 20182011₹10.07 Cr (FY 2025)Active
Director12 Mar 20182018₹1.9 Lakh (FY 2024)Active
Designated Partner15 Apr 20232014Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Verdeen Chemicals Private Limited U24233UP2013PTC055906
Director01 Sep 20182013₹17.32 Cr (FY 2025)Active
Bvg Tech Private Limited U24200RJ2019PTC064847
Director07 May 20192019Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bvg Tech Private Limited
Exeens Capital Advisors Private Limited
Delicare Lifesciences Private Limited
Aavyana Advisors Llp
Premium access

Shareholding and investment profile for Ashwani Deedwania

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashwani Deedwania

Ashwani Deedwania currently holds 3 directorships: Delicare Lifesciences Private Limited (Director, since 26 May 2018, revenue ₹10.07 Cr (FY 2025)); Exeens Capital Advisors Private Limited (Director, since 12 Mar 2018, revenue ₹1.9 Lakh (FY 2024)); Aavyana Advisors Llp (Designated Partner, since 15 Apr 2023).

Ashwani Deedwania was first appointed on 12 Mar 2018 as Director at Exeens Capital Advisors Private Limited. The most recent appointment on record is 15 Apr 2023 at Aavyana Advisors Llp.

The 2 current companies of Ashwani Deedwania that report revenue have a combined latest revenue of ₹10.09 Cr: Delicare Lifesciences Private Limited ₹10.07 Cr (FY 2025); Exeens Capital Advisors Private Limited ₹1.9 Lakh (FY 2024).

Ashwani Deedwania held 2 earlier board appointments: Verdeen Chemicals Private Limited (Director, 01 Sep 2018 to 31 Mar 2022); Bvg Tech Private Limited (Director, from 07 May 2019).

The current boards of Ashwani Deedwania's companies include Jiggar Lakshmichand Savla (Delicare Lifesciences Private Limited), Narayanlal Mishrilal Sarada (Delicare Lifesciences Private Limited), Nilesh Shah (Delicare Lifesciences Private Limited), Sanchit Agarwal (Delicare Lifesciences Private Limited), Priyesh Karia Ambalal (Exeens Capital Advisors Private Limited), Shivani Prahlad Bansal (Aavyana Advisors Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available